MedMal Direct Ins Co
Major Rating Factors:
Poor long-term capitalization index (0.3 on a scale of 0 to 10) based on weak current risk adjusted capital (severe and moderate loss scenarios). A history of deficient reserves (0.5) that places pressure on both capital and profits. In four of the last five years reserves (two year development) were between 21.5% and 88.0% deficient. Weak profitability index (1.8) with operating losses during 2021, 2022, 2023 and 2024.
Other Rating Factors:
Vulnerable liquidity (2.6) as a spike in claims may stretch capacity. Fair overall results on stability tests (4.6) including weak risk adjusted capital in prior years and negative cash flow from operations for 2024. The largest net exposure for one risk is acceptable at 2.3% of capital.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
D - Limited diversification of general business, policy, and/or investment risk.
F - Negative cash flow.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (100.0%)
Licensed in:
AL, FL, GA, IL, IN, MO, NC, OH, OK, PA, TX, VA
Principal Investments:
Investment grade bonds (65.5%), common stock (0.4%), other (34.1%)
Corporate Info
Group Affiliation
Integris Group Incorporated
Investment Rating
--
Company Address
76 South Laura Street
Jacksonville, FL 32202
Jacksonville, FL 32202
Phone Number
(904) 482-4068
NAIC Number
13793
Website
Largest Affiliates